Warner Pharmaceuticals (688799): Short-term performance is under pressure, and clinical trials of new drugs are progressing steadily
Warner Pharmaceuticals (688799): Integrated platform for raw materials and formulations showcases powerful development and new drugs to drive future growth
Warner Pharmaceuticals (688799): Policy supports alternative development of rare and endangered Chinese herbal medicines, and the company takes the lead in benefiting and is expected to share the broad market
Warner Pharmaceuticals (688799): The new antidepressant ZG-001 capsule completed phase I clinical trials and is expected to become a revolutionary “BIC” variety in the field of depression
Warner Pharmaceuticals (688799): Laying out the artificial replacement of original innovative drugs for depression and endangered medicinal herbs to create a comprehensive platform for integrated drug formulations
Warner Pharmaceuticals (688799): Integrated development of raw materials and formulations, the pipeline of endangered medicinal herbs is progressing steadily